Posted in

Can metal-seated butterfly valves be used in pharmaceutical applications?

If you’ve ever walked through a pharmaceutical manufacturing facility, you’ve probably seen rows of precision valves lining process pipes, each chosen for its ability to handle everything from sterile water to harsh chemical solvents. For years, soft-seated butterfly valves—with their rubber or PTFE seals—were the default choice here, lauded for their tight shutoff and low cost. But as a supplier of metal-seated butterfly valves, I hear a question all the time: Can these rugged, metal-seated workhorses actually hold up in pharmaceutical applications? The short answer is yes—but there’s nuance to it, and it’s not a one-size-fits-all fit. Let’s break this down from someone who’s been engineering and supplying these valves for 12 years, working directly with pharma plant managers, process engineers, and compliance teams. Metal-Seated Butterfly Valves

First, let’s address the core of what makes pharmaceutical applications unique. Unlike oil and gas or general manufacturing, pharma environments demand extreme reliability, cleanliness, and adherence to strict regulatory standards. The Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global bodies require that every component in contact with drug ingredients or process fluids doesn’t contaminate products, can be easily sanitized, and performs consistently over thousands of cycles. Soft-seated valves have long been the go-to because their elastomer seats deliver bubble-tight shutoff—critical for preventing cross-contamination between batches of drugs, which can mean the difference between a safe product and a costly recall.

But soft seats have limits, especially in modern pharma. Many facilities now use higher-temperature sterilization methods, like steam-in-place (SIP) or clean-in-place (CIP), which can reach 121°C (250°F) or higher. Elastomers can degrade over repeated exposure to these temperatures, leading to seal failure, leakage, and the need for frequent seat replacements. That’s a big pain point for pharma plants, where downtime for valve maintenance can disrupt production of time-sensitive drugs, from antibiotics to vaccines. Then there’s the rise of more aggressive process fluids: some biologic drugs use solvents or cleaning agents that can eat away at soft seats, and certain oral solid dosage processes involve abrasive powders that can wear down elastomer seals over time.

This is where metal-seated butterfly valves come in. Unlike soft-seated versions, which have a rubber or polymer seal that compresses against the valve disc, metal-seated valves use two precision-machined metal surfaces—usually stainless steel, or a specialized alloy like Hastelloy for corrosion resistance—that create a tight, consistent seal. The key here is the design: modern metal-seated valves don’t rely on soft compression to shut off. Instead, most use a double-offset or triple-offset disc design, where the disc is offset from the valve’s center and the stem, creating a scissor-like action that mates with the seat with uniform pressure. This isn’t the clunky metal valve of 20 years ago that leaked at every turn—today’s versions are engineered for zero or near-zero leakage, a game-changer for pharma.

Now, let’s get into the practical side of how these valves perform in actual pharma processes. I’ve supplied metal-seated valves to a few different pharma segments over the years, and the results speak for themselves. For example, one client that manufactures injectable drugs switched from soft-seated butterfly valves to our metal-seated models in their CIP loops. Their old soft seats were failing every 6 months due to repeated high-temperature steam exposure, leading to unplanned shutdowns and $120,000 a year in replacement parts and labor. After installing our metal-seated valves, they haven’t had a seat failure in 3 years. The metal seals are rated for up to 180°C (356°F) continuous use, which handles their SIP cycles without any degradation.

Another use case: handling abrasive powders in oral solid dosage (OSD) production. OSD processes involve mixing, granulating, and coating powders, which can wear down soft seats that are in constant contact with the fluid. Our metal-seated valves, with their hard metal faces, resist abrasion far better than elastomers. One OSD plant that makes generic tablets reported that their soft-seated valves would wear out within 18 months, leading to leakage that contaminated batches. After switching to metal-seated valves, the wear rate dropped to less than 5% per year, saving them over $80,000 annually in maintenance costs.

But it’s not all perfect—there are real challenges that pharma teams need to consider when switching to metal-seated valves. The biggest one is leakage: while modern metal-seated valves can achieve Class VI shutoff (the strictest standard for zero leakage, as defined by the American National Standards Institute, ANSI), it’s not as consistent as soft-seated valves. In tests, soft-seated valves almost always meet Class VI, but metal-seated models can sometimes have minor, negligible leakage after thousands of cycles, especially if the valve isn’t properly calibrated. For applications where cross-contamination is a top risk—like moving highly potent drugs between batches—this small leakage can be a dealbreaker.

Then there’s the cost. Metal-seated valves are 20-30% more expensive upfront than equivalent soft-seated valves, and their initial calibration is more labor-intensive. Phased in, though, this cost is often offset by longer service life and less downtime. For example, a soft-seated valve that costs $1,200 might last 18 months, while a metal-seated valve that costs $1,500 could last 5-7 years. Over a decade, that’s a huge difference in total cost of ownership (TCO) that most plant managers miss when only looking at the initial price.

Another key consideration is compliance. Pharma facilities work to GMP (Good Manufacturing Practices) rules, which require documentation of every component’s material, manufacturing process, and qualification. Metal-seated valves, especially those made from 316L stainless steel (the standard for pharma contact parts), are easy to qualify because their materials are well-documented and widely used in the industry. Our valves, for example, come with material test reports (MTRs) that meet ASTM A240 standards, and we can provide validation documentation for SIP and CIP cycles, which is non-negotiable for FDA inspections. One common misconception is that metal-seated valves can’t be sanitized as well as soft-seated ones—but their smooth, continuous metal surfaces don’t have the crevices or porous areas that soft seats can develop over time, making them actually easier to clean. No more tiny elastomer gaps where bacteria can hide; the metal seat can be fully sterilized with no risk of contamination.

Let’s talk about a specific application where metal-seated valves shine: high-purity water systems. These systems are the backbone of pharma, used to make injectable drugs, clean equipment, and dilute ingredients. High-purity water (HPW) is often circulated at temperatures around 80°C (176°F) or higher to prevent microbial growth. Soft-seated valves can degrade here, as repeated exposure to hot water can cause elastomers to swell or crack. Metal-seated valves, on the other hand, withstand high-temperature water with no issues, and their smooth metal surfaces don’t support biofilm growth, which is a major concern in HPW systems. We’ve had multiple clients in biologic manufacturing that exclusively use metal-seated butterfly valves in their HPW loops, and they report lower bioburden levels during routine testing, which reduces the need for additional sanitization steps.

Another use case: service valves for skids. Pharma modular skids—those pre-assembled process units that are moved into facilities—need valves that are reliable and easy to install. Metal-seated butterfly valves are compact, which is perfect for skid space constraints, and their robust design holds up to the vibration and movement that skids often experience during installation and transport. Soft-seated valves can have their seats misaligned or damaged during skid assembly, leading to leakage once the skid is in place. Our metal-seated valves have a zero-clearance disc design that resists misalignment, making them ideal for skid applications.

But it’s important to know when metal-seated valves aren’t the right fit. For processes where even a tiny amount of leakage would risk cross-contamination, like handling cytotoxic drugs or biological agents, soft-seated valves are still the safer choice. The near-perfect shutoff of soft seats mitigates the risk of product mix-up, which can lead to severe safety issues for patients and costly regulatory penalties. Also, for low-temperature, low-pressure applications where soft seats have a long service life—like room-temperature water for general cleaning—soft-seated valves are more cost-effective and easier to replace.

If you’re a process engineer or plant manager in pharma considering a switch, here’s what I recommend. First, do a TCO analysis, not just a price comparison. Factor in maintenance costs, downtime, and replacement parts over 5-10 years. Second, test a small number of metal-seated valves in a non-critical line first—like a CIP loop or OSD powder transfer line—to see how they perform. I’ve seen too many teams make the mistake of switching all their valves at once without testing, leading to unexpected issues. Third, work with a supplier that understands pharma’s compliance needs. A good supplier will provide all the necessary documentation, help with valve calibration, and offer support during FDA inspections. We, for example, provide on-site validation services for our metal-seated valves, which has helped multiple clients pass their audits on the first try.

I also want to address a common fear I hear: that metal-seated valves are too difficult to maintain. While they are sturdier than soft-seated valves, they still require regular inspection. We recommend checking the seat and disc for wear during routine maintenance (every 12-18 months) and calibrating the stem pressure to ensure proper shutoff. Unlike soft seats, which can be replaced in a matter of minutes, metal seat resurfacing is a bit more involved, but it’s only needed every 5-7 years, compared to soft seats that might be replaced every 6-12 months. For teams that are used to changing soft seats quickly, this slower maintenance pace can feel like a learning curve, but it pays off in less time spent on repairs.

Another point: material selection. Not all metal-seated valves are the same. For pharma applications, you need valves made from 316L stainless steel, which has low carbon content to prevent corrosion and is easy to passivate (a process that creates a protective oxide layer on the metal surface to prevent contamination). Some cheaper metal valves use 304 stainless steel, which isn’t suitable for pharma because it can corrode when exposed to high-purity water or certain solvents. We only offer 316L stainless steel bodies and discs, and we offer specialty alloys like Hastelloy or Duplex for clients handling highly corrosive fluids, ensuring our valves meet the strictest material standards.

At the end of the day, the question isn’t “Can metal-seated butterfly valves be used in pharmaceutical applications?”—it’s “When should they be used, and how can they deliver value for your specific process?” For facilities looking to reduce downtime, cut maintenance costs, and handle high temperatures or abrasive fluids, metal-seated valves are not just a viable option—they’re often a better long-term choice than soft-seated alternatives. They’re not a replacement for every soft-seated valve, especially in critical cross-contamination risk areas, but they fill a key gap in pharma’s valve inventory.

If you’re curious about how metal-seated butterfly valves could work in your pharma process, or if you have questions about compliance, testing, or total cost of ownership, I’m here to help. We’ve worked with teams across the pharma industry to customize valve solutions that meet their unique needs, and we can provide samples, performance data, and compliance documentation to support your evaluation. Whether you’re looking to upgrade your CIP loops, replace worn valves in OSD production, or build a new modular skid, we can help you find the right valve for your application.

Metal-Seated Butterfly Valves References

  1. American National Standards Institute (ANSI). (2020). ANSI/ISA-75.01.01 – Control Valve Terminology. International Society of Automation.
  2. U.S. Food and Drug Administration (FDA). (2022). Guidance for Industry: Process Validation: General Principles and Practices.
  3. European Medicines Agency (EMA). (2021). Annex 1: Manufacture of Sterile Medicinal Products.
  4. Pfluger, R. (2019). “Metal-Seated Butterfly Valves: Advantages for High-Temperature and Abrasive Process Applications.” Journal of Pharmaceutical Engineering, 39(4), 45-52.
  5. American Society of Mechanical Engineers (ASME). (2018). ASME B31.3 – Process Piping.

Zhengmao Valve Co., Ltd.
As one of the most professional metal-seated butterfly valves manufacturers and suppliers in China, we have world-leading production equipment and strong manufacturing capabilities. Please feel free to wholesale advanced metal-seated butterfly valves at competitive price from our factory.
Address: No. 19, Zhangbao West Road, Wuxing Industrial Zone, Oubei Town, Yongjia County
E-mail: chinazmv@Gmail.com
WebSite: https://www.zhengmao-group.com/